STOCK TITAN

Cadre Hldgs Inc SEC Filings

CDRE NYSE

Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Cadre Holdings, Inc. (NYSE: CDRE) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a Delaware corporation listed on the New York Stock Exchange under the symbol CDRE, Cadre submits current reports on Form 8‑K, annual and quarterly reports, and other documents that describe its operations in safety and survivability equipment for law enforcement, first responder, military and nuclear markets.

In its Form 8‑K filings, Cadre reports material events such as quarterly financial results, investor presentations and significant transactions. For example, the company has filed 8‑Ks to furnish earnings press releases and slide presentations, and to disclose a securities purchase agreement to acquire TYR Tactical, a manufacturer of tactical gear and equipment for military, law enforcement and government agencies worldwide. These filings also confirm details such as Cadre’s incorporation in Delaware and its CDRE listing on the New York Stock Exchange.

Through its SEC reports, Cadre discusses non‑GAAP financial measures including EBITDA, adjusted EBITDA and adjusted EBITDA margin, explaining how these metrics relate to its GAAP results. Filings may also describe contract awards, like blast exposure monitoring programs handled by its Med‑Eng subsidiary, and provide additional context on acquisitions in nuclear safety and tactical equipment.

On Stock Titan, investors can review Cadre’s SEC filings alongside AI‑powered summaries that clarify key points in lengthy documents. Real‑time updates from EDGAR help users track new 8‑Ks, 10‑Qs and 10‑Ks as they are filed, while insider and governance‑related disclosures can be used to analyze management decisions and capital allocation. This page is a resource for understanding how Cadre communicates its financial performance, strategic transactions and risk factors through its regulatory filings.

Rhea-AI Summary

Cadre Holdings (CDRE) – Form 4 filed 06/23/2025. CEO, Chairman and 10% owner Warren B. Kanders disclosed two open-market sales executed through his controlled entity, Kanders SAF, LLC.

  • 06/18/2025: 50,000 common shares sold at a weighted-average price of $33.95.
  • 06/20/2025: 50,000 common shares sold at a weighted-average price of $33.01.

The combined 100,000-share disposal generated roughly $3.3 million in gross proceeds. Following the transactions, Kanders SAF’s holding declined to 10,241,192 shares. Additional positions remain unchanged: 45,584 shares held directly, 1,305,650 in Warren B. Kanders’ Roth IRA, and 23,450 in his spouse’s Roth IRA.

No derivative activity was reported, and the filing does not indicate the sales were made under a Rule 10b5-1 plan. While the sale size is modest relative to Kanders’ total ownership, it represents the first reported share reduction in 2025 and may be monitored by investors for sentiment signals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Cadre Hldgs (CDRE) SEC filings are available on StockTitan?

StockTitan tracks 42 SEC filings for Cadre Hldgs (CDRE), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cadre Hldgs (CDRE)?

The most recent SEC filing for Cadre Hldgs (CDRE) was filed on June 23, 2025.

CDRE Rankings

CDRE Stock Data

1.28B
31.06M
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE

CDRE RSS Feed